A citation-based method for searching scientific literature

Juan Bautista Blaquier, Gonzalo Recondo. Drugs Context 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Lorenzo Galluzzi, Ilio Vitale, Sarah Warren, Sandy Adjemian, Patrizia Agostinis, Aitziber Buqué Martinez, Timothy A Chan, George Coukos, Sandra Demaria, Eric Deutsch,[...]. J Immunother Cancer 2020
363
100

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth.
Mengmeng Niu, Jing Xu, Yang Liu, Yuhuang Li, Tao He, Liangping Ding, Yajun He, Yong Yi, Fengtian Li, Rongtian Guo,[...]. Nat Commun 2021
8
100


Sirt1 protects from K-Ras-driven lung carcinogenesis.
Luis Filipe Costa-Machado, Roberto Martín-Hernández, Miguel Ángel Sanchez-Luengo, Katharina Hess, Claudia Vales-Villamarin, Marta Barradas, Cian Lynch, Daniel de la Nava, Alberto Diaz-Ruiz, Rafael de Cabo,[...]. EMBO Rep 2018
14
100

ROS1 rearrangements define a unique molecular class of lung cancers.
Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang,[...]. J Clin Oncol 2012
100






Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients.
Maria Esperanza Rodriguez-Ruiz, Aitziber Buqué, Michal Hensler, Jonathan Chen, Norma Bloy, Giulia Petroni, Ai Sato, Takahiro Yamazaki, Jitka Fucikova, Lorenzo Galluzzi. Oncoimmunology 2019
70
100

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.
Jitka Fucikova, Iva Truxova, Michal Hensler, Etienne Becht, Lenka Kasikova, Irena Moserova, Sarka Vosahlikova, Jana Klouckova, Sarah E Church, Isabelle Cremer,[...]. Blood 2016
82
100

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.
Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Virna Cortez-Retamozo, Christopher Garris, Ferdinando Pucci, Takahiro Yamazaki, Vichnou Poirier-Colame, Andita Newton, Younes Redouane,[...]. Immunity 2016
565
100

Sex specific function of epithelial STAT3 signaling in pathogenesis of K-ras mutant lung cancer.
Mauricio S Caetano, Maya Hassane, Hieu T Van, Emmanuel Bugarin, Amber M Cumpian, Christina L McDowell, Carolina Gonzalez Cavazos, Huiyuan Zhang, Shanshan Deng, Lixia Diao,[...]. Nat Commun 2018
44
100

Mutationally-activated PI3'-kinase-α promotes de-differentiation of lung tumors initiated by the BRAFV600E oncoprotein kinase.
J Edward van Veen, Michael Scherzer, Julia Boshuizen, Mollee Chu, Annie Liu, Allison Landman, Shon Green, Christy Trejo, Martin McMahon. Elife 2019
10
100

RAS oncogenes: the first 30 years.
Marcos Malumbres, Mariano Barbacid. Nat Rev Cancer 2003
100


Targeting immunogenic cell death in cancer.
Asma Ahmed, Stephen W G Tait. Mol Oncol 2020
130
100

DA-Raf, a dominant-negative antagonist of the Ras-ERK pathway, is a putative tumor suppressor.
Emiri Kanno, Osamu Kawasaki, Kazuya Takahashi, Kazunori Takano, Takeshi Endo. Exp Cell Res 2018
5
100

Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1-CD8+ Tumor-Infiltrating T Cells.
Sema Kurtulus, Asaf Madi, Giulia Escobar, Max Klapholz, Jackson Nyman, Elena Christian, Mathias Pawlak, Danielle Dionne, Junrong Xia, Orit Rozenblatt-Rosen,[...]. Immunity 2019
285
100

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.
Ryohei Katayama, Alice T Shaw, Tahsin M Khan, Mari Mino-Kenudson, Benjamin J Solomon, Balazs Halmos, Nicholas A Jessop, John C Wain, Alan Tien Yeo, Cyril Benes,[...]. Sci Transl Med 2012
948
100

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target.
Xiuning Le, Marcelo V Negrao, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel McGrail, Monique Nilsson, Jacqulyne Robichaux, Irene Guijarro Munoz, Sonia Patel,[...]. J Thorac Oncol 2021
38
100

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
100

Raf kinases: function, regulation and role in human cancer.
Deborah T Leicht, Vitaly Balan, Alexander Kaplun, Vinita Singh-Gupta, Ludmila Kaplun, Melissa Dobson, Guri Tzivion. Biochim Biophys Acta 2007
184
100

Immunogenic cell death in colon cancer prevention and therapy.
Hang Ruan, Brian J Leibowitz, Lin Zhang, Jian Yu. Mol Carcinog 2020
34
100

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
Elisabeth Müller, Panagiotis F Christopoulos, Sanjib Halder, Anna Lunde, Kahsai Beraki, Martin Speth, Inger Øynebråten, Alexandre Corthay. Front Immunol 2017
114
100


Progesterone receptor membrane component 1 leads to erlotinib resistance, initiating crosstalk of Wnt/β-catenin and NF-κB pathways, in lung adenocarcinoma cells.
Ying Lin, Kazuma Higashisaka, Takuya Shintani, Ayaka Maki, Sachiyo Hanamuro, Yuya Haga, Shinichiro Maeda, Hirofumi Tsujino, Kazuya Nagano, Yasushi Fujio,[...]. Sci Rep 2020
13
100

Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
Rie Furukawa, Hiroyuki Inoue, Yasuto Yoneshima, Hirono Tsutsumi, Eiji Iwama, Yuki Ikematsu, Nobuhisa Ando, Yoshimasa Shiraishi, Keiichi Ota, Kentaro Tanaka,[...]. Lung Cancer 2021
4
100

Damage-Associated Molecular Patterns in the Course of Lung Cancer--A Review.
M Łagiedo, J Sikora, M Kaczmarek. Scand J Immunol 2015
15
100

Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Hiroyuki Inoue, Hirono Tsutsumi, Kentaro Tanaka, Eiji Iwama, Yoshimasa Shiraishi, Aiko Hirayama, Takayuki Nakanishi, Hiroyuki Ando, Maako Nakajima, Seiji Shinozaki,[...]. Transl Lung Cancer Res 2021
7
100

Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
Judith Müller, Oscar Krijgsman, Jennifer Tsoi, Lidia Robert, Willy Hugo, Chunying Song, Xiangju Kong, Patricia A Possik, Paulien D M Cornelissen-Steijger, Marnix H Geukes Foppen,[...]. Nat Commun 2014
385
100

JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progression.
Julian Mohrherr, Marcel Haber, Kristina Breitenecker, Petra Aigner, Stefan Moritsch, Viktor Voronin, Robert Eferl, Richard Moriggl, Dagmar Stoiber, Balázs Győrffy,[...]. Int J Cancer 2019
34
100

ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1-SHP2 Signaling Pathway in Non-Small Cell Lung Cancer.
Liangliang Cai, Jianchun Duan, Li Qian, Zhijie Wang, Shuhang Wang, Sini Li, Chao Wang, Jie Zhao, Xue Zhang, Hua Bai,[...]. Front Immunol 2020
2
100


Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
Narjust Duma, Rafael Santana-Davila, Julian R Molina. Mayo Clin Proc 2019
684
100

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy.
Nicole Rufo, Abhishek D Garg, Patrizia Agostinis. Trends Cancer 2017
88
100

AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells.
Maria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, Tuan Zea Tan, Ning Lu, Laura Trachsel-Moncho, Gro V Røsland, Muntequa I Siraji, Monica Hellesøy, Austin Rayford,[...]. J Thorac Oncol 2020
42
100

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.
Abhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, Thais Baert, Raymond B Birge, José Manuel Bravo-San Pedro, Karine Breckpot, David Brough, Ricardo Chaurio, Mara Cirone,[...]. Front Immunol 2015
248
100

Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules.
Hao-Tien Wang, Hsin-I Lee, Jih-Huong Guo, Shih-Hui Chen, Zhe-Kang Liao, Kai-Wen Huang, Pao-Ling Torng, Lih-Hwa Hwang. Int J Cancer 2012
36
100


Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells.
Wei Cao, Ying Liu, Ran Zhang, Bo Zhang, Teng Wang, Xianbing Zhu, Lin Mei, Hongbo Chen, Hongling Zhang, Pinghong Ming,[...]. Sci Rep 2015
88
100

ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer.
Yingchang Li, Zhihua Ye, Shuai Chen, Zhiwen Pan, Qianghua Zhou, Yi-Zhuo Li, Wen-di Shuai, Chun-Mei Kuang, Qi-Hua Peng, Wei Shi,[...]. Int J Cancer 2018
16
100

Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
Jin-Young Lee, Oualid Talhi, Dongman Jang, Claudia Cerella, Anthoula Gaigneaux, Kyu-Won Kim, Jung Weon Lee, Mario Dicato, Khaldoun Bachari, Byung Woo Han,[...]. Cancer Lett 2018
26
100

Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer.
Juan R Cubillos-Ruiz, Eslam Mohamed, Paulo C Rodriguez. J Immunother Cancer 2017
53
100

Drugging the undruggable RAS: Mission possible?
Adrienne D Cox, Stephen W Fesik, Alec C Kimmelman, Ji Luo, Channing J Der. Nat Rev Drug Discov 2014
100

Autophagy facilitates the release of immunogenic signals following chemotherapy in 3D models of mesothelioma.
Carlo Follo, Yao Cheng, William G Richards, Raphael Bueno, V Courtney Broaddus. Mol Carcinog 2019
13
100

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
S W Morris, M N Kirstein, M B Valentine, K G Dittmer, D N Shapiro, D L Saltman, A T Look. Science 1994
100

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.
Adam S Crystal, Alice T Shaw, Lecia V Sequist, Luc Friboulet, Matthew J Niederst, Elizabeth L Lockerman, Rosa L Frias, Justin F Gainor, Arnaud Amzallag, Patricia Greninger,[...]. Science 2014
498
100

Combinatorial strategies for the induction of immunogenic cell death.
Lucillia Bezu, Ligia C Gomes-de-Silva, Heleen Dewitte, Karine Breckpot, Jitka Fucikova, Radek Spisek, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer. Front Immunol 2015
262
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.